Cargando…

Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis

Valproic acid (VPA) is a commonly used drug for epilepsy, psychiatric disorders and migraine and is frequently used in neurosurgical intensive care units. Though most of its side-effects are mild and transient, certain idiosyncratic side-effects have been attributed to VPA. Valproate induced hyperam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Amandeep, Suri, Ashish, Sharma, Bhawani S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118513/ https://www.ncbi.nlm.nih.gov/pubmed/25097360 http://dx.doi.org/10.4103/0972-5229.136076

Ejemplares similares

Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014)

Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017)

A Case of Valproate Induced Hyperammonemic Encephalopathy
por: Tarafdar, Surjit, et al.
Publicado: (2011)

Valproate induced hyperammonemic encephalopathy treated by haemodialysis
por: Chauhan, Vinay Singh, et al.
Publicado: (2017)

Valproate-induced hyperammonemic encephalopathy: a case report
por: Shah, Suhal, et al.
Publicado: (2020)

A Case of Valproate-Induced Hyperammonemic Encephalopathy
por: Zafar, Faraaz, et al.
Publicado: (2020)

Valproate-induced hyperammonemic encephalopathy: A reminder of rare complication of valproate
por: Gurjar, Mohan, et al.
Publicado: (2011)

Valproate-induced hyperammonemic encephalopathy. A case report
por: Cerame, A., et al.
Publicado: (2022)

Valproate-Induced Hyperammonemic Encephalopathy Causing New-Onset Seizures
por: Sammar, Aleena, et al.
Publicado: (2023)

Valproate-associated hyperammonemic encephalopathy in subarachnoid hemorrhage: a diagnosis to consider
por: Fuellis, Vivian, et al.
Publicado: (2022)

Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
por: Vivekanandan, S., et al.
Publicado: (2010)

Hypothyroidism may exacerbate valproate-related hyperammonemic delirium
por: Hung, Chung-Chieh, et al.
Publicado: (2016)

Multiple Myeloma-Induced Hyperammonemic Encephalopathy
por: Murtaza, Ghulam, et al.
Publicado: (2017)

Pronounced reversible hyperammonemic encephalopathy associated with combined valproate–topiramate therapy in a 7-year-old girl
por: Weise, Sebastian, et al.
Publicado: (2015)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Recurring hyperammonemic encephalopathy induced by bacteria usually not producing urease
por: Cordano, Christian, et al.
Publicado: (2014)

A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine
por: Chahin, Michael, et al.
Publicado: (2020)

MRI Findings in Acute Hyperammonemic Encephalopathy: Three Cases of Different Etiologies: Teaching Point: To recognize MRI findings in acute hyperammonemic encephalopathy
por: Reis, Elisabeth, et al.
Publicado: (2020)

Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014)

A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021)

Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023)

Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy
por: Yi, Hee Jung, et al.
Publicado: (2016)

Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy
por: Ihoriya, Hiromi, et al.
Publicado: (2018)

Acute Plasma Cell Leukemia Presenting as Primary Hyperammonemic Encephalopathy
por: Patel, Dveet, et al.
Publicado: (2020)

Hyperammonemic Encephalopathy: A Rare Presentation of Relapsed Multiple Myeloma
por: Menakuru, Sasmith R., et al.
Publicado: (2023)

A Treatable Encephalopathy in a Peritoneal Dialysis Patient - Cefepime-Induced Encephalopathy
por: Khoo, Ching Soong, et al.
Publicado: (2019)

Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review
por: Guo, Xiaopeng, et al.
Publicado: (2017)

Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
por: Ahn, Jin-Ok, et al.
Publicado: (2016)

A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency
por: Kankananarachchi, Imalke, et al.
Publicado: (2021)

The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
por: Narita, Koichi, et al.
Publicado: (2020)

Delayed Cerebral Abnormalities in Acute Hyperammonemic Encephalopathy
por: Ito, Hiroshi, et al.
Publicado: (2020)

Reversible hyperammonemic encephalopathy after gastrointestinal bleeding
por: Boku, Keishun, et al.
Publicado: (2021)

Hyperammonemic Encephalopathy Secondary to Urinary Tract Infection
por: Gorantla, Asher, et al.
Publicado: (2022)

Valproic-induced Hyperammonemic Encephalopathy in a Known Case of Epilepsy
por: Imam, Syed F, et al.
Publicado: (2017)

Valproic acid-induced hyperammonemic encephalopathy: a clinical case
por: Felizardo, M., et al.
Publicado: (2022)

Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis: A case report
por: Haroon, Sabrina, et al.
Publicado: (2021)

Ceftriaxone-Induced Acute Encephalopathy in a Peritoneal Dialysis Patient
por: Safadi, Sami, et al.
Publicado: (2014)

Valproic acid-induced hyperammonemic encephalopathy – a potentially fatal adverse drug reaction
por: Sousa, Carla
Publicado: (2013)

Adult‐onset noncirrhotic hyperammonemic encephalopathy probably caused by splenorenal shunts
por: Yoshizawa, Kazuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a08t601i01n18kift023grs7hu